Overview
Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway
Status:
Unknown status
Unknown status
Trial end date:
2017-12-01
2017-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Hypothesis: Prucalopride can mimic electrical stimulation of the abdominal vagus nerve and has an anti-inflammatory effect. Aims: In the present pilot study, the investigators want to evaluate the anti-inflammatory effect of prucalopride. The following aims are formulated: 1. to show that prucalopride has a similar inflammatory effect as abdominal vagus nerve stimulation (VNS) 2. to evaluate whether prucalopride leads to accelerated post-operative recoveryPhase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Katholieke Universiteit Leuven
KU LeuvenCollaborator:
Universitaire Ziekenhuizen LeuvenTreatments:
Anti-Inflammatory Agents
Cholinergic Agents
Prucalopride
Criteria
Inclusion Criteria:- patients undergoing partial or full resection of the pancreas due to a benign or
malignant tumor
Exclusion Criteria:
- adjuvant radiotherapy
- evident intra-abdominal inflammation (diagnosed by imaging and/or laboratory results,
including an abscess or cholecystitis)
- chronic pancreatitis
- pancreatic polypeptide producing endocrine tumor
- American Society of Anesthesiologists physical-health status classification (ASA-PS)>3
- Poorly regulated diabetes (>200 mg/dl (=11 mmol/l))